Company / EPS (Basic)
Xenetic Biosciences, Inc. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$2.57
FY2025
5-year range
-$4.61 / -$0.55
FY2022-FY2025
Trend
+5.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-4.61 to $-2.57 over the past 2 years.
Based on SEC 10-K filings.
-2.57 in FY2025.
Improved from $-4.61 to $-2.57 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 5.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.57 | +5.2% |
| FY2024 | -$2.71 | +41.2% |
| FY2023 | -$4.61 | -738.2% |
| FY2022 | -$0.55 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026